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Background: The Patient Activation Measure (PAM) consists of 13 items and assesses patient (or consumer)
self-reported knowledge, skills, and confidence for self-management of one’s health or chronic condition. The aim
of this study was to translate the original American version of the PAM13 into German and to test the psychometric
properties of the German version in an elderly, multimorbid population with various chronic conditions.
Methods: Translation was performed by a standardized forward-backward translation process. The PAM13 was sent
to 9.075 participants enrolled in a randomized controlled study. 4.306 participants responded to the questionnaire.
Descriptive and reliability analyses were carried out. To examine scale properties, Andrich’s Rasch Rating Scale
Model was fitted.
Results: The internal consistency is good (α = 0.88) and the item-rest-correlations were found as strong to moderate.
The unidimensionality of the construct was confirmed, with a variance explanation of 40.9% and good model-fits for
the Rasch model. However, the lowest response options were very rarely used across all items (below 5%) and ranking
order of items according to their difficulty was substantially different from that of the American version. Differential item
functioning (DIF) was found in subgroups (sex, age, health status), but differences were small.
Conclusion: The German version of the PAM13 showed acceptable reliability and the model-fit statistics confirmed the
Rasch model. The different ranking order of the items and the unfair distribution of the response options suggest
further research on validation and revision of the construct.Background
Increasing ageing, longer life expectancy and advances
in health care lead to a greater number of people living
with chronic illnesses and growing demands on the health
care systems [1,2]. As technological progress alone cannot
compete with the resulting challenges for health care sys-
tems, there are various efforts to improve the quality of
chronic illness care. One focus of these efforts has recently
been put on the patient activation for self-management
one’s diseases [3]. Activation of patients, referring to the
confidence that enables patients to become actively en-
gaged in their health, is central within new models of
chronic illness care, like for example the framework of the
Chronic Care Model [4,5]. In this framework, improvement
of self-management strategies strengthens the patients’ acti-
vation levels in the course of the treatment in addition
to other components (e.g. proactive team interaction).* Correspondence: j.zill@uke.de
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reproduction in any medium, provided the orSelf-management of chronic diseases refers to aspects
like medication use, life-style changes, and health be-
havior changes to prevent long-term complications or
increase adherence to treatment regimens.
Current findings show that the degree of patients’ acti-
vation differs significantly for those with a low activation
level having higher costs than patients with a high ac-
tivation level [6]. Additionally, research shows that if
patients are more engaged and play a more active role
in their health care is associated with greater satisfac-
tion with care, increased adherence, more knowledge,
improved health status and a decreased utilization of
health care services [7].
However, especially older patients with various dis-
eases have problems participating actively in their treat-
ment. Success of self-management is likely to depend on
self-management skills and patient activation [8]. There-
fore, it is important to identify patients lacking these
skills, to develop and evaluate interventions to enhance
the skills necessary for activation and to tailor supportThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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individual patients’ level of activation. To attain these
goals, it is crucial to have valid and reliable assessment
methods for the individual level of activation.
Patient activation
In 2004, Hibbard et al. [9] developed a model of patient
activation supposed to inform about strategies to increase
patient engagement in health. Patient activation is defined
as the degree to which a patient knows that one must en-
gage actively in managing his disease, its consequences and
the corresponding health care, and the degree one feels able
to meet the challenges of that patients’ role [10]. Expert
consensus and patient focus groups [11] identified four
relevant elements for coping with chronic diseases:
knowledge, skills, confidence and behaviors critical for
coping with chronic diseases. Hibbard and colleagues
[9] conceptualized patient activation as a hierarchically
structured developmental process with four stages of
activation, where individuals can progress through to
become fully activated in their health management. (1)
Believes Active Role Important (2) Confidence and
Knowledge to Take Action (3) Taking Action (4) Staying
the Course under Stress.
The patient activation measure (PAM)
Hibbard and colleagues developed the Patient Activation
Measure (PAM) on this above mentioned concept of
patient activation. The PAM was originally developed
as a 22-item version using qualitative methods, clas-
sical test theory, and Rasch analysis [10]. The result is a
unidimensional, interval-level, Guttman-type scale [12].
Subsequently, a 13-item short version was developed in
two versions: one for chronic conditions and one for
non-chronic conditions, with minor distinctions in the
wording. The short form of the PAM has the same psy-
chometric properties as the longer version and was
found to be as valid and reliable [11].
Since the development of the PAM, a growing
amount of research, mainly from the US, has shown that
increased scores on the PAM are associated to a broad
range of health-related outcomes. In the original validation
studies by Hibbard and colleagues, higher activation scores
corresponded with better health, lower rates of health
care utilization, higher engagement in disease-specific
self-management behaviors, a higher engagement in con-
sumerist health behaviors, and preventive behaviors [9,11].
Further studies suggested that patient activation is strongly
related to health behaviors e.g. engagement in regular exer-
cise, managing stress, paying attention to diet and taking
diabetes medications, less smoking behavior, or increased
probability of having a breast cancer screen [12-15].
So far, the original English version of the PAM13
has been translated into Danish [16], Dutch [17], andNorwegian [18]. Furthermore, the concept has been applied
to other conditions [19].
The aims of the present study were:
 to translate and adapt the American short form of
the Patient Activation Measure (PAM13) into a
German version.
 to establish the psychometric properties of the
German version of the PAM13 in an multimorbid
population with various chronic conditions.
Methods
The PAM13 version for chronic conditions is the version
most commonly used and will be described in further
detail and analyzed in this study.
Translation and adaptation
The original American version of the PAM13 was trans-
lated into German by a German native speaker with excel-
lent knowledge of English and a background in psychology
and health services research. Back-translation was done by
a native English speaker in order to control for the original
meaning of the words to be maintained. Any discrepancies
in the translation process were discussed with both transla-
tors and two further team members of the research project
who are experienced in translation processes of instruments
and the field of research.
Participants
The German version of the PAM13 was sent to N= 9.075
participants enrolled in a randomized controlled study set
up to compare a telephone based health coaching with usual
care (German Clinical Trials Register, DRKS00000584). The
participants were all German health fund members and
older than 18 years with a diagnosis of at least one chronic
disease based on the routine data of a health fund. Their risk
of rehospitalization within the next year was predicted higher
than 50% based on health care costs, ICD-diagnoses, age
and gender. The German version of the PAM13 was sent
out as a paper-pencil version as part of a larger survey on
patient reported outcomes to intervention and control group
participants. Participants received a follow-up survey 12, 24
and 36 months after the first questionnaire. For this valid-
ation study only data from the first measure point (baseline)
were used, before any intervention was administered.
Ethics
Ethic approval was attained from the Ethics Committee of
the State Chamber of Physicians in Hamburg (Germany).
All participants gave informed content.
Measures
To assess the demographic background of the patients,
questions regarding gender, age, education, current work
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the questionnaire. Participants’ self-reported-health
was determined with the first item of the short-form
health survey (SF-12) [20]. Patient activation was measured
with the German version of the PAM13 (see Table 1 for
the content of the original version of the PAM13; see
Additional file 1 for the German version of the PAM13).
Each of the 13 items can be answered with one of four
possible response options, which are “disagree strongly”
(1), “disagree” (2), “agree” (3), “agree strongly” (4). A fifth
response option “not applicable” (N/A) was given in the
American version for all items. In the German version only
item 4 had a fifth response option, namely “I do not take
medications”. The authors considered this wording bet-
ter understandable. The remaining items are general
statements which should be applicable to all partici-
pants. Based on responses to the 13-item measure, the
score is calculated by adding up the raw scores and
mapping up the value onto a scale of 0–100 indicating
strength of agreement with the 13 items. The final score
can be assigned to one of the four levels of activation. A
higher score indicates that the patient is likely to partici-
pate more actively in health care processes and takes
more responsibility for his or her health.
Statistical methods and analysis
For a better comparability of results of the German
PAM13 to the American, Dutch, and Danish versions,
the psychometric elements of the PAM13 were assessed in
two phases.
In a first step, the data were analyzed for missing data.
Participants with more than 30% missing values in the
PAM13 were excluded from further analyses. For partici-
pants with missing data less than 30%, missing values were
imputed using expectation-maximization procedure withinTable 1 The original American version of the Patient Activatio
Item
1 When all is said and done, I am the person who is responsible for
2 Taking an active role in my own health care is the most important
3 I am confident that I can take actions that will help prevent or min
4 I know what each of my prescribed medications do
5 I am confident that I can tell when I need to go get medical care
6 I am confident I can tell my health care provider concerns I have e
7 I am confident that I can follow through on medical treatments I n
8 I understand the nature and causes of my health condition(s)
9 I know the different medical treatment options available for my he
10 I have been able to maintain the lifestyle changes for my health th
11 I know how to prevent further problems with my health condition
12 I am confident I can figure out solutions when new situations or p
13 I am confident that I can maintain lifestyle changes like diet and ethe statistical software PASW Statistics (Version 18.0).
Furthermore, data were described with respect to the
percentage of missing responses, frequencies for the
response options, mean, standard deviation and median
for each item.
The internal consistency of the instrument was exam-
ined using Cronbach’s α for each item, as well as the
inter-item and the item-rest correlation (Pearson’s r). An
α of 0.70 was defined as the lowest acceptable value
[21]. For the item-rest correlation correlations r ≥ 0.10
were considered as weak and correlations of r ≥ 0.30 as
moderate and of r ≥ 0.50 as strong [22]. In the second
step of the examination of the psychometric elements of
the German version of the PAM13 the Andrich’s Rasch
Rating Scale Model was used [23,24]. For this purpose
the data was imported to the free statistical program
R (R version 2.15.2, The R Foundation for Statistical
Computing); the package eRm was used for the ana-
lysis of the Rating Scale Model [25]. Item and person
parameters, model-fit-statistics, and differential item
functioning (DIF) were investigated.
The Rasch model calibrates the difficulty of the items
in relation to the response probabilities of a person,
presuming that a single construct drives item responses
[26]. This implies that the response of a person to an
item informs on the person’s level on this construct. The
probability of a person for a positive response of an item
is in the Rasch model a logistic function of the item diffi-
culty and person ability [27]. This logistic function is an
interval scale where the midpoint is 0. The items are or-
dered on the scale respectively to their difficulty level;
items on the top of the scale have lower probability that
a person scores high on it (“more difficult” items) and
on the bottom of the scale items have higher probability
to be responded to (“less difficult” items) [23]. The itemn Measure (13-item-form) [11]
managing my health condition
factor in determining my health and ability to function
imize some symptoms or problems associated with my health condition
and when I can handle a health problem myself
ven when he or she does not ask
eed to do at home
alth condition
at I have made
roblems arise with my health condition
xercise even during times of stress
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Rasch model contain information of the precision and
monotonicity of the response category used [24]. If esti-
mates are disordered, this indicates that the categories
do not sufficiently reflect the intervals of the latent vari-
able and response categories were not used. The model
posits that thresholds that increase by at least 1.4 logits
reflect sufficient distinction of response options and
measurement model fit to reflect the sufficient distinc-
tion between the response options and measurement
model fit. More than 5.0 logits indicate that intervals in
the variable are too large [23,28].
Unidimensionality and local independence of the 13
items were examined as a requirement for the Rasch
model [23]. This was addressed by using a Principal
Components Analysis (PCA). The aim of the PCA of
residuals is to extract one common factor that explains
most of the variance in the analyzed items. The condition
was considered as violated if other factors besides the com-
mon factor appear to have eigenvalues greater than 3 [27].
To test whether the items fit the expected model, the
mean square information-weighted statistic (infit) and the
outlier-sensitive statistic (outfit), were computed. The infit
statistics are more sensitive to irregular response patterns
according to the person’s ability level, whereas the outfit
statistics informs about the degree of the item fit [23]. A
good fit with the Rasch model indicate indices between
0.6 and 1.4 [16].
Equivalent to the Danish version of the PAM13, DIF
was assessed from the Rasch model using the Andersen’s
Likelihood Ratio Test. There should be no differences in
the probability to endorse a certain item for subgroups
[26,29]. Thus, DIF can be interpreted as a sign for the
fairness of a test [16]. The DIF was assessed the Andersen’s
Likelihood Ratio Test [25] for subgroups in sex, education,
age and self-rated health.
Results
Participants
A total of N = 4.309 responded to the questionnaire, this
is a response rate of 47.5%. Participants with more than
30% missing data were excluded from further analysis.
After exclusion the total sample was N = 4.018. Participants
were between 19 and 87 years old, the mean age was
67 years. Gender was distributed almost evenly with 54.8%
female and 45.2% male participants. Regarding the ICD-10
diagnosis, 66.4% of the participants had arthrosis, 67.3% a
heart insufficiency or coronary artery disease, 37.7% a lung
disease, 41.9% cancer, 40.1% depression, 46.3% diabetes,
90.2% hypertension, 43.1% an anxiety disorder, and 38.5%
adipositas. Most of the participants had more than one
diagnosis. Education of the participants (N = 3.231) was di-
vided into three levels similar to the validation studies from
the USA, Netherlands and Denmark. Low educational level(no apprenticeship = 8.88%, other apprenticeship = 6.50%),
middle educational level (apprenticeship = 64.9%), high edu-
cational level (technical college = 14.3%; university = 6.3%).
Results are presented in Table 2.
Furthermore, Table 2 shows the mean activation scores
of the German sample. In this sample men (68.1) have
slightly higher activation score than women (66.9). In the
distinction by age groups, the group with an age 65 from
74 years had the highest activation score (67.8) and the
group of the over 85 years old the lowest (53.1). Regarding
self-rated health patient activation is found being highest
for the group with excellent health (85.1) and lowest
for the group with poor health (58.7). When differentiating
for diagnosis, the highest activation scores were found for
the group of patients with cancer (67.5) and the lowest with
depression (64.9).
Psychometric properties
For the data description, the percentage of missing
responses, the frequencies for the response options
mean, standard deviation (SD) and median for each
item were assessed (Table 3).
In general, acceptance of the items was high with
percentages of missings per item ranging between 0.4%
(item 6) and 3.9% (item 12). Only item 4 had 14.8% of
missing answers.
The frequencies of the response categories showed little
use of the category “strongly disagree” (from 0.7% to 4.7%)
and moderate frequency for “disagree” (from 4.0% to 27.9%).
The category “agree” was used with the highest frequency
(from 55.0% to 70.2%) and the category “strongly agree” was
moderately used (from 8.9% to 29.7%). The category “not
applicable” for item four was used by 2.6% of the sample.
The median score was 3 for all items, the mean scores
varied from 2.72 (item 12) to 3.20 (item 6). The last three
items of the scale have a lower mean score in comparison
to the items at the beginning of the questionnaire. The
items did not constantly follow the sequence from higher
scores to lower scores, which were presented for the
original American scale. Standard deviations varied
0.56 (item 2) to 0.72 (item 11).
Regarding internal consistency, a Cronbach’s α of 0.88
was found for the sum scale. The item-rest-correlation,
indicating the correlations between items and the sum
of the other items were moderate to strong and ranged
from 0.46 to 0.63 supporting the assumption of unidimen-
sionality of the construct.
Rasch analysis
One of the criteria to conduct adequate functioning of
rating scale categories is that the category frequencies
are fairly similarly distributed across items [27]. This cri-
terion was not fulfilled as the response option “strongly
disagree” was hardly used by the participants. Therefore,
Table 2 Demographic data and mean activation scores of
the PAM13 for the German sample
N % PAM 13 Score
Sample 4018 100 67.1
Gender
Male 1796 44.7 68.1
Female 2180 54.3 66.9
Age Groups
−44 116 2.9 64.4
45-54 272 6.8 64.5
55-64 839 20.9 66.6
65-74 2093 52.1 67.8
75-84 646 16.1 67.1
+85 10 53.1
Education
Low 2353 58.6 66.5
Middle 673 16.7 67.2
High 205 5.1 70.7
Self-rated Health
Poor 469 11.7 58.7
Fair 2057 51.2 65.0
Good 1324 33.0 72.2
Very Good 59 1.5 82.0
Excellent 11 0.27 85.1
Diagnosis
Heart problem 2704 67.3 66.9
Arthrosis 2667 66.4 66.8
Depression 1616 40.1 64.9
Lung Disease 1514 37.7 66.1
Cancer 1684 41.9 67.5
Diabetes 1859 46.3 67.3
Hypertension 3626 90.3 67.1
Anxiety 1731 43.1 65.9
Adipositas 1548 38.5 66.4
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“strongly disagree” and “disagree” into one response
category. Further analyses were computed with this
data set with only three response options. (Results for
the data set including four response options can be
found in the Additional file 2: Table S1).
Test of unidimensionality
The PCA for the testing of unidimensionality as a require-
ment for the Rasch model, could be confirmed. A total of
40.9% of the variance was explained by one factor with an
eigenvalue of 5.3.Rating scale model
The item statistics ranged from 0.68 to 1.03 for the
infit (infit MSQ) and from 0.65 to 1.22 for the outfit
(outfit MSQ) all indicating a good fit of the Rasch
model. The thresholds increase by at least 1.4 logits show-
ing sufficient distinction between the response options and
measurement model fit. None of the thresholds exceeds
the limit of 5.0 logits (Table 4). The item difficulty was
presented by the location parameters of the items. Results
show that the original order of difficulties found for the
American version could not be confirmed for the German
PAM13 (Table 4). For example, item 1 with a location
parameter of 1.74 was more difficult for the German
sample than item 8 with a location parameter of 1.27.
Items 4 and 7 could be located at the same difficulty
levels as the corresponding items of the American version.
Consistent with the original version, items 11, 12 and 13
showed the highest difficulties.
The Rasch person-item map (Figure 1) displays the
person parameter distribution on the latent dimension
and the item difficulties. The black dots show the mean
item-difficulty and white dots reflect the ranges of thresh-
olds, as presented in Table 4. Persons on the left side of
the scale report being less activated than persons on the
right side of the scale.
Differential item functioning
The DIF test for sex showed statistically significant dif-
ferences for women and men (LR-value: 122.61, df = 13,
p = 0.001). Differences were most prominent for item 4
and 5 located on the second level “confidence and know-
ledge to take action”, which were slightly more difficult to
endorse for men than for women. Item 1, located on the
first level of the construct “believes active role is important”,
was slightly more difficult for women.
DIF according to education was tested by comparing
the low education group with the collapsed middle and
high education group. For education no DIF in subgroups
was found (LR-value: 14.74, df = 13, p = 0.324).
Furthermore, the DIF was tested for subgroups in age.
The sample was divided into two groups (younger than
44 years to 64 years and 65 years to older than 85). The
test revealed significant differences (LR-value: 184.02,
df = 13, p < 0.001). Item 2 belonging to the first level of
patient activation, item 3 located on the second level of
the construct which is “confidence and knowledge to
take action”, item 11 located on the third level “taking
action” and item 12 belonging to the fourth level “staying
in course under stress” were more difficult to endorse for
the older age group. Item 13, also located on the fourth
level was slightly easier to endorse for the older age group
than for the younger age group.
Finally, the DIF was tested for subgroups in self-rated
health. Two subgroups were formed with the first group
Table 3 Data description of the German version of the PAM13
Item N* Missing values* Strongly disagree* Disagree* Agree* Strongly agree* Mean* SD* Inter-rest-correlation*
1 3970 1.2% 137 479 2359 1043 3.07 0.71 0.46
(3.4%) (11.9%) (58.7%) (26.0%)
2 3961 1.4% 38 160 2693 1127 3.22 0.56 0.51
(0.9%) (4.0%) (67.0%) (28.0%)
3 3958 1.5% 127 629 2531 731 2.96 0.68 0.53
(3.7%) (15.7%) (63%) (18.2%)
4 3422 14.8% 38 265 2534 1079 3.19 0.59 0.51
(0.9%) (6.6%) (63.1%) (26.8%)
5 3977 1.0% 117 652 2482 767 2.97 0.68 0.51
(2.9%) (16.2%) (61.8%) (19.1%)
6 4003 0.4% 41 291 2493 1193 3.20 0.61 0.53
(1.0%) (7.2%) (62.0%) (29.7%)
7 3988 0.7% 30 275 2612 1101 3.19 0.58 0.59
(0.7%) (6.8%) (65.0%) (27.4%)
8 3987 0.8% 47 242 2391 1238 3.12 0.63 0.60
(1.2%) (8.5%) (59.5%) (30.8%)
9 3983 0.9% 87 821 2380 730 2.93 0.68 0.63
(2.2%) (20.4%) (59.2%) (18.2%)
10 3970 1.2% 50 489 2820 730 3.02 0.58 0.63
(1.2%) (12.2%) (70.2%) (16.4%)
11 3971 1.2% 158 1120 2208 532 2.78 0.72 0.65
(3.9%) (27.9%) (55.0%) (13.2%)
12 3862 3.9% 189 1123 2348 358 2.72 0.69 0.55
(4.7%) (27.9%) (58.4%) (8.9%)
13 3869 3.7% 152 1006 2457 403 2.77 0.67 0.48
(3.8%) (25.0%) (61.1%) (10.0%)
*based on the imputed data sample N = 4.018 and for item 4 N = 3.913 (n = 105 (2.6%) answered item 4 with “I do not take medicine”).
Table 4 Item statistics
Item Location parameter Threshold 1 Threshold 2 SE Outfit MSQ Infit MSQ
2 1.17 −0.86 3.21 0.03 0.85 0.83
6 1.25 −0.78 3.29 0.03 0.94 0.94
8 1.27 −0.76 3.30 0.03 0.84 0.88
4 1.33 −0.70 3.37 0.03 0.95 0.92
7 1.33 −0.71 3.36 0.03 0.74 0.77
1 1.74 −0.29 3.78 0.03 1.22 0.94
10 2.09 0.06 4.13 0.03 0.65 0.68
5 2.23 0.19 4.26 0.03 1.03 1.03
3 2.26 0.22 4.29 0.03 1.00 1.01
9 2.42 0.39 4.46 0.03 0.88 0.90
11 3.04 1.00 5.07 0.03 0.87 0.88
13 3.05 1.01 5.09 0.03 1.05 1.03
12 3.26 1.23 5.30 0.03 0.93 0.93
The items are ranked according to their difficulty (location parameter). Information on thresholds, standard error (SE), and fit statistics (outfit and infit MSQ).
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Figure 1 Person item-map.
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very good or good and a second group including persons
with a fair or poor rating of their health. The results showed
evidence of DIF (LR-value: 268.47, df = 13, p < 0.001).
Differences were found for the items 2 (level 1), the items
6, 7 (level 2), and 9, 10 (level 3). These items were easier for
the subgroup in which self-rated-health was fair or poor.
DIF was especially found for the second cut off value
between the response options “agree” and “totally agree”.
The graphical output for the DIF testing can be found
in the Additional file 3: (Figure S1 to Figure S4).
Discussion
The German version of the PAM13 was tested in a
multimorbid population with various chronic conditions.
The German version showed good internal consistency
(Cronbach’s α = 0.88) and inter-rest correlations were mod-
erate to strong. The findings for the internal consistency
are comparable to the Danish and the Dutch version of the
instrument. For the American version, no Cronbach’s α was
published. The analysis of the frequencies of the item
response options revealed that the response category
“strongly disagree” was very rarely used and the category
“disagree” was frequented very seldom as well. The re-
sponse category “agree” was chosen the most. The irregu-
lar use of response options can be interpreted as a lack of
fit of the response scale with the study sample.
The Rasch analysis of the items showed that the ori-
ginal difficulty ranking order of the items could not be
confirmed. The differences in the item order indicate
that the German population found other items easier or
more difficult to respond to than the American popula-
tion. E.g. item 1 and 3 were rated as more difficult in theGerman sample than item 6 and item 8. Consistent with
the American version, items 11, 12 and 13 were the
most difficult items of the scale, yet the order differed
slightly in the German version (11, 13, 12). This could
be due to specifics of this sample (age, multimorbidity,
various chronic diseases) or cultural differences between
the American and the German samples. Since the Dutch
and Danish validation studies could not confirm the
original item order either, differences in the European
and American understanding of health system may be
the cause of these results. Comparing the Dutch, Danish
and German item order, few similarities can be found, the
Danish and Dutch item orders being more similar to the
original American item order. E.g. item 7 was also less dif-
ficult for the Danish sample and item 5 more difficult in
comparison to the original order of the American version.
Item 3 was found as very difficult in the German sample
but was in the “correct” order in the Danish validation. It
is important to note that the Dutch validation study did
not use Rasch modeling. The Norwegian validation study
of the PAM13 is not available in English and therefore no
comparisons were made with this study.
Comparing the activation scores of subgroups in the
German sample, self-rated health is the most distinguish-
ing variable, which is similar to the results of the Dutch,
Danish and American validation studies. However, as all
studies use a cross-sectional design they cannot answer
the question of cause and effect. The activation scores for
the diagnosis subgroups differ only slightly with the lowest
scores attained by the depression and anxiety group.
Considering that patients with these diagnoses generally
have low self-esteem, are caught up in negative thoughts
and emotions, and usually express low levels of action
and self-management, this result is not surprising, but
scores in this subgroup are still considerably high [10,17].
When testing for DIF, several differences for the difficulty
of certain items were revealed in the subgroups of sex, age,
and self-rated health, but these differences can be seen
as rather small.
Referring to the current state of research little is known
about the cross-cultural validity of the PAM13. A Danish,
Dutch, and Norwegian translation have been analyzed
so far and translations into further other languages and
testing of the psychometric properties among different
cultures remains outstanding [11]. Furthermore, com-
parison of the existing validation studies is limited be-
cause of different cultural contexts, sample sizes, age
groups and diagnoses.
Strengths and limitations
A strength of this study is the sample size of 4.018 persons,
which is notably bigger than those of the other validation
studies. Moreover, the sample presents a heterogeneous
group of patients with various chronic conditions similar to
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that a heterogeneous sample scores on all levels of activa-
tion [16], but this could not be confirmed in the present
study, as ceiling effects were very high. Another strength of
this study is the high responsiveness of the items with only
0.4% to 3.9% missings per item. An exception was item 14
with 14.8% missing values. The reason for this deviating
result can only presumed by the authors. Since this item is
the only one which clearly refers to medication, it is pos-
sible that some participants are not firm on their medica-
tion and did not feel comfortable to respond to this item.
As limitations of the study the following points are dis-
cussed. First, the comparability of the German translation
to other validation studies might be limited due to the fact,
that the response options were changed by omitting the
option “not applicable”. The authors were of the opinion
that besides item 4 all statements should be applicable
and the response option “not applicable” might cause a
loss of information. Nevertheless, this could be reconsid-
ered in further validation studies.
Second, after a first analysis the response categories
“strongly disagree” and “disagree” were combined into one
response category. Again this might be limit the compar-
ability of this study, but adequate functioning of rating scale
categories requires that the category frequencies are fairly
similarly distributed across items [27]. The authors still did
the calculation on the data with four response options and
provided these results in the Additional file 2: Table S1).
Third, the overall response rate of the study was low
with 47.5%. When comparing non-responders to the
responders it was found that they differed in age with
the responders being older (mean = 67 years) than the
non-responders (mean = 65.5 years). There were slightly
more women than men with the non-responders but this
might due to the fact, that slightly more women were in-
cluded into the study in the first place. There was no other
information e.g. about the health of the non-responders as
this information was only accessible when the survey was
completed. It is possible that especially non-responders
have lower PAM scores, the responders of this study par-
ticipants scored very high on the PAM and low levels of
the PAM construct were rarely used.
As a final limitation it should be mentioned that during
the translation process, comprehensibility and equivalence
were not discussed with groups of patients as it was done
in the Danish validation study. Only researchers were
involved in our translation process.
Implications for practice and further research
With regard to the current problems the health care sys-
tem has to face, e.g. a growing number of elderly people
and increasing numbers of people living with a chronic
disease [2], enhancing patients’ involvement in their health-
care is one option to improve the situation. Especially olderpatients with various diseases have difficulties to get in-
volved in their treatment. Measuring the level of a person’s
activation can help to improve the success of interventions
by tailoring them according to the individual’s level of acti-
vation and the corresponding readiness to be engaged. To
that end, the PAM13 can be a useful instrument. However,
different aspects are recommended to address in further re-
search before using the German version of the PAM13 in
practice. First, longitudinal studies and interventions studies
with the German version of the PAM13 are necessary to
test for change over time and effects of patient activation.
Intervention studies are mainly carried out in the United
States so far. For example, Shively et al. [30] found a signifi-
cant increase of the PAM13 scores for patients with chronic
heart failure after participating in a self-management train-
ing for six months. First studies that are testing the instru-
ment and its correlations with different outcome measures
have been also done in the Netherlands. Rademakers and
collegues [31] examined the effect of patient activation and
health literacy on provider choice, and found that low levels
on these constructs were negatively associated with active
provider choice. Second, it would be recommended to
test the German PAM13 with other samples, e.g. also
non-clinical samples. Earlier American studies (e.g. [32,33])
found that the PAM13’s psychometric properties are also
robust in samples with employees. Activation was found as
directly related to the health status and job performance
measures. Finally, the different item order found for the
German version as well as the differences for subgroups in
sex, age and self-rated health for the probability to endorse
a certain item raise the question whether the Rating Scale
Model is the best fitting model for this construct or
whether e.g. a Partial Credit Model, which is less restricted,
would show a better fit. Moreover, the high ceiling effects
that leaded to the merging of the first and second response
option were a problem in this validation study. Future
research should test again whether the original model is
applicable to the German population.
Conclusion
Thus far, only a very few solely validation studies regarding
the PAM13 were conducted in other countries than the
USA. Most of the intervention and validation studies were
done by the developers of PAM13 (Hibbard and colleagues)
or by researchers who are associated with the team. With
the validation of the German version of the PAM13, a
further study investigating the construct is available.
The results of the German validation study indicate
that the reliability of the construct and model fits for the
Rating Scale Model are good. Nevertheless, the original
order of the items was not confirmed and the irregular
use of the response options led to difficulties for the ana-
lyses and calls for more research and development on the
construct. Before using the German version of the PAM13
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validity are highly recommended.
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